April 17/18, 2018 – Dr. Glickman presented 30 day results of the Animal Implants data at the Charing Cross International Symposium, London, England. Drs. Elias and Glickman also hosted a session on implant techniques for the VenoValve.

April 16, 2018 – Dr. Meissner also presented at the Charing Cross meeting on the “ impact of a Valve in the deep Venous system” highlighting the VenoValve and its potential.

January, 2018 – Dr. Elias presented early animal study results of the VenoValve at the International Phlebology Society in Melbourne, Australia

November, 2017 – Dr. Elias presented updates on the VenoValve at the Veith Symposium in NYC and plans for animal studies.

October, 2017 – Dr. Marc Glickman, CMO of HJL participated in a round table discussion published in Vein Magazine on Artificial Vein Valves, discussing the VenoValve.

April 7, 2017 - Hancock Jaffe Lab has sponsored a CME event at the Venous Symposium on April 7th in New York City. The event is tailored to discuss options for treating patients with CVI.

April, 2017 - In Vascular News, April 2017, news of the VenoValve and potential impact on patients was discussed in detail in the article. Dr. Elias was lead author and his thoughts about how this valve will impact patients with CVI was discussed in detail.

February 15, 2017 - Dr. Steve Elias, Principal investigator for the VenoValve human trial will present to the American Venous Forum on February 15, 2017 in New Orleans on The biomechanics of the VenoValve and its impact on patients.

November 17, 2016 - Dr. Marc Glickman, MD, Chief Medical Officer for HJL, presented at the Veith Vascular Symposium in New York City on November 17, 2016 on “Impact of the VenoValve in patients with Deep Venous Insufficiency”.